INDEPENDENT NEWS

AFT Pharmaceuticals completes first deal in South America

Published: Thu 20 Jun 2019 02:00 PM
Market and Media release 20 June 2019
AFT Pharmaceuticals’ completes first deal in South America
AFT signs Maxigesic® Licensing Agreement with Barcelona-based Galenicum Vitae S.L.U for Colombia, Peru and Chile.
AFT Pharmaceuticals today announces it has established a beachhead in South America after signing a licensing agreement with Galenicum Vitae.
Galenicum is a Barcelona-based pharmaceutical company with offices across South America and around the globe. It plans to market, sell and distribute AFT’s patented combination analgesic, Maxigesic®, in Colombia, Peru and Chile. Products covered by the new agreement include tablets and oral liquid for paediatric use.
AFT Managing Director, Dr Hartley Atkinson, says: “We are pleased to be making progress on licensing agreements in Latin America. These agreements will be a welcome addition to the Central American markets already licensed, with sales now underway - or due to start – in the current financial year in El Salvador, Guatemala, Honduras, Costa Rica and Nicaragua.”
Dr Atkinson said AFT expects registration approvals in the territories covered by the Galenicum agreement to occur prior to the end of 2021 with sales occurring in the following year.
Galenicum Vitae’s CEO, Sergio Malagrida, said: “For us, including a product such us Maxigesic® in our portfolio represents a great opportunity to provide an innovative product reinforcing our market offering. We believe that this will be the initial launch of a future greater line of products”.
Peru, Colombia and Chile have a combined population of almost 100 million people and the combined retail current value of the over-the-counter pain relief market is NZ$749 million [Euromonitor, 2018.].
Maxigesic® is a patented, fixed ratio of ibuprofen for anti-inflammation management and paracetamol (also called acetaminophen) for pain management.

Next in Business, Science, and Tech

Government moves to protect elite soils
By: New Zealand Government
Calls for overhaul of gene-technology regulations
By: Royal Society Te Aparangi
Card spending dips in July
By: BusinessDesk
Govt takes more action to reduce waste
By: New Zealand Government
Fonterra Provides Update on Earnings
By: Fonterra
Potatoes vs people: govt moves to protect top vege-growing
By: BusinessDesk
New Zealand First Backs Plans to Protect Productive Land
By: New Zealand First Party
LGNZ cautious as government pits potatoes against houses
By: Local Government NZ
HortNZ welcomes safeguarding of country’s best growing soils
By: Horticulture NZ
Anti-housing rules to keep Kiwis locked out
By: New Zealand Taxpayers' Union
Productive farming land dug up for housing
By: RNZ
Gene editing regulations – Expert Reaction
By: Science Media Centre
Government responds to report on gene editing
By: New Zealand Government
Government can’t continue to ignore biotech
By: New Zealand National Party
Genetic Regulation Overhaul Overdue
By: New Zealand Life Sciences Network
View as: DESKTOP | MOBILEWe're in BETA! Send Feedback © Scoop Media